In the News
Genomes to Life
OASCR and GTL
DOE Microbial Cell Project
Human Genome Draft
Genome Perspective
Honor for DeLisi
New NIH Institute
Structural Genomics
Imaging Structures
Synchrotron Use
Proteome Organisation
Breast Cancer Research
Gene Expressions Used
Nuclear Medicine
Nuclear Medicine Labs
Toxicogenomics Center
Kettering Prize
Zeta Phi Beta Conference
Microbial Genomes
Sloan-DOE Fellowships
Ribosomes Illuminated
In Memoriam: Walter Goad

Comparative Genomics
Model Organism Studies
Sushi Delicacy
Arabidopsis Sequence
AAAS Prize
Microbial Conference
Flyer; "Microbe Month"
VISTA Software
Mouse
ORNL Mouse Program
MicroCAT Scanner Used
Draft Sequence Achieved
NCBI Mouse Resources
Human-Mouse Comparisons
MGI Allele Searching

Web, Publications, Resources
Next-Generation Computing
HGMIS Resources
NSF QSB Report
Structural Biology Basics
Minorities and the HGP
HGP Educational Kit
Testing, Counseling Resources
Biotech, ELSI Websites
Biotech Encyclopedia
ASM Report
Nature Yearbook
Next Wave Publication
High-School Curriculum
Education CD-ROMs
Exploring DNA in the Classroom

Funding
US Genome Research Funding
UK Scholarships, PostDocs

Meeting Calendars & Acronyms
Genome and Biotechnology Meetings
Training Courses and Workshops
Acronyms

HGN archives and subscriptions

Human Genome Project Information home

Some Highlights of BER-Funded Research in Nuclear Medicine

Brookhaven National Laboratory, New York
One of the world's leading laboratories for the design, synthesis, and application of radiopharmaceuticals for such priorities as substance abuse, aging and degenerative diseases, and the biology of tumors.

Lawrence Berkeley National Laboratory, California
Specialized instrument development to improve detection of prostate, breast, and other cancers for such priorities as SPECT imaging for brain studies of mental illness. New radiotracers to study aging, heart disease, and cancer.

Oak Ridge National Laboratory, Tennessee
Genesis of BER when ORNL made available a vast selection of radionuclides for nuclear medicine research. Studies of new radiopharmaceuticals' potential for diagnostic and therapeutic applications in cancer and coronary artery disease.

Memorial Sloan-Kettering Cancer Center, New York
Pioneering work in the use of "monoclonal antibodies" to treat cancer. Novel ways to produce a variety of radionuclides to treat lymphoma, leukemia, and prostate cancer.

University of California, Los Angeles
New ways to image the biology and genetics of several diseases, including cancer, diabetes, heart disease, Alzheimer's disease, and Parkinson's disease. Pioneers in PET and microPET, which allows scientists to watch cells at work in the living person or mouse.

Washington University, St. Louis, Missouri
Innovative use of radionuclides in medicine. Important contributions to PET. Development of new organic carrier molecules and a new class of PET radio-pharmaceuticals based on metal radionuclides and first hormone receptor agents.

University of Michigan, Ann Arbor
Research in the chemical design and synthesis of radiopharmaceuticals and their implementation in PET and SPECT brain-chemistry studies. Development of computer science for nuclear medicine imaging systems. Insight into several neurological disorders that affect movement, memory, aging, and dementia.

The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v11n3-4).